The herpes simplex virus type 1 UL3 transcript starts within the UL3 open reading frame and encodes a 224-amino-acid protein

Journal of Virology

Volumn 81, Issue 19, 2007, Pages 10524-10531

  Markovitz, Nancy S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MESSENGER RNA; VIRUS VECTOR;

ARTICLE; CELL LINEAGE; GENE CONSTRUCT; GENE FUNCTION; GENE MUTATION; GENETIC CODE; HERPES SIMPLEX VIRUS 1; LIFE CYCLE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION; START CODON; TRANSCRIPTION INITIATION SITE; UL3 GENE; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSCRIPTION;

AMINO ACIDS; BASE SEQUENCE; CODON, INITIATOR; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PROTEIN BIOSYNTHESIS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 34648827831     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00123-07     Document Type: Article

References (39)

1. Baines, J. D., and B. Roizman. 1991. The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture. J. Virol. 65:938-944.
2. Bharatan, N. S., M. A. Currier, and T. P. Cripe. 2002. Differential susceptibility of pediatric sarcoma cells to oncolysis by conditionally replication-competent herpes simplex viruses. J. Pediatr. Hematol. Oncol. 24:447-453.
3. Dambach, M. J., J. Trecki, N. Martin, and N. S. Markovitz. 2006. Oncolytic viruses derived from the γ34.5-deleted herpes simplex virus recombinant R3616 encode a truncated UL3 protein. Mol. Ther. 13:891-898.
4. Ghiasi, H., G. C. Perng, S. Cai, A. B. Nesburn, and S. L. Wechsler. 1996. The UL3 open reading frame of herpes simplex virus type 1 codes for a phosphoprotein. Virus Res. 44:137-142.
5. Harrow, S., J. Harland, R. Mabbs, R. Petty, M. Fraser, D. Hadley, J. Patterson, S. M. Brown, and R. Rampling. 2004. HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival. Gene Ther. 11:1648-1658.
6. Hu, J. C. C., Z. Han, B. Liu, M. Robinson, R. Branston, R. C. Coombes, and R. S. Coffin. 2003. Combination of OncoVEX with chemotherapy for cancer treatment. Cancer Gene Ther. 10:67.
7. Hu, J. C., M. J. Booth, G. Tripuraneni, D. Davies, S. A. A. Zaidi, M. Tamburo de Bella, M. J. Slade, S. B. Marley, M. Y. A. Gordon, R. S. Coffin, R. C. Coombes, and T. Kamalati. 2006. A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow. Clin. Cancer Res. 12:6853-6862.
8. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
9. Igarashi, K., R. Fawl, R. J. Roller, and B. Roizman. 1993. Construction and properties of a recombinant herpes simplex virus 1 lacking both S-component origins of DNA synthesis. J. Virol. 67:2123-2132.
10. Jahedi, S., N. S. Markovitz, F. Filatov, and B. Roizman. 1999. Colocalization of the herpes simplex virus 1 UL4 protein with infected cell protein 22 in small, dense nuclear structures formed prior to onset of DNA synthesis. J. Virol. 73:5132-5138.
11. Klupp, B. G., H. Granzow, W. Fuchs, E. Mundt, and T. C. Mettenleiter. 2004. Pseudorabies virus UL3 gene codes for a nuclear protein which is dispensable for viral replication. J. Virol. 78:464-472.
12. Kozak, M. 2005. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361:13-37.
13. Kramm, C. M., M. Chase, U. Herrlinger, A. Jacobs, P. A. Pechan, N. G. Rainov, M. SenaEsteves, M. Aghi, F. H. Barnett, E. A. Chiocca, and X. O. Breakefield. 1997. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum. Gene Ther. 8:2057-2068.
14. Liu, R., R. L. Martuza, and S. D. Rabkin. 2005. Intracarotid delivery of oncolytic HSV vector G47Δ to metastatic breast cancer in the brain. Gene Ther. 12:647-654.
15. L3 protein of herpes simplex virus 1 is translated predominantly from the second in-frame methionine codon and is subject to at least two posttranslational modifications. J. Virol. 73:8010-8018.
16. L4 proteins and of ICP22 only when the latter protein is present. J. Virol. 74:523-528.
17. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA-sequence of the long unique region in the genome of herpes-simplex virus type-1. J. Gen. Virol. 69:1531-1574.
18. Mineta, T., S. D. Rabkin, T. Yazaki, W. D. Hunter, and R. L. Martuza. 1995. Attenuated multi-mutated herpes-simples virus-1 for the treatment of malignant gliomas. Nat. Med. 1:938-943.
19. Mori, I., and Y. Nishiyama. 2006. Accessory genes define the relationship between the herpes simplex virus and its host. Microbes Infect. 8:2556-2562.
20. O'Toole, J. M., M. Aubert, A. Kotsakis, and J. A. Blaho. 2003. Mutation of the protein tyrosine kinase consensus site in the herpes simplex virus 1 alpha 22 gene alters ICP22 posttranslational modification. Virology 305:153-167.
21. Parikh, N. S., M. A. Currier, Y. Y. Mahller, L. C. Adams, B. Di Pasquale, M. H. Collins, and T. P. Cripe. 2005. Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus type 5 for the treatment of high-risk neuroblastomas in preclinical models. Pediatr. Blood Cancer 44: 469-478.
22. Post, L. E., S. Mackem, and B. Roizman. 1981. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell 24:555-565.
23. Post, L. E., and B. Roizman. 1981. A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25:227-232.
24. Purves, F. C., W. O. Ogle, and B. Roizman. 1993. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA 90:6701-6705.
25. Pyles, R. B., and R. L. Thompson. 1994. Evidence that the herpes-simplex virus type-1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J. Virol. 68:4963-4972.
26. Pyles, R. B., and R. L. Thompson. 1994. Mutations in accessory DNA replicating functions alter the relative mutation frequency of herpes simplex virus type 1 strains in cultured murine cells. J. Virol. 68:4514-4524.
27. Pyles, R. B., R. E. Warnick, C. L. Chalk, B. E. Szantl, and L. M. Parysek. 1997. A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors. Hum. Gene Ther. 8:533-544.
28. Roizman, B., and D. M. Knipe. 2001. Herpes simplex viruses and their replication, p. 2399-2457. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
29. Schaefer, B. C. 1995. Revolutions in rapid amplification of cDNA ends: new strategies for polymerase chain reaction cloning of full-length cDNA ends. Anal. Biochem. 227:255-273.
30. Sears, A. E., I. W. Halliburton, B. Meignier, S. Silver, and B. Roizman. 1985. Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J. Virol. 55:338-346.
31. Singh, J., and E. K. Wagner. 1993. Transcriptional analysis of the herpes-simplex virus type 1 region containing the TR(L)-U(L) junction. Virology 196:220-231.
32. Tang, S., and Z. M. Zheng. 2002. Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site. J. Biol. Chem. 277:14547-14556.
33. Thomas, S. K., Y. McGrath, M. J. Robinson, P. A. Reay, and R. S. Coffin. 2003. Herpes simplex virus as a vaccine delivery platform. Cancer Gene Ther. 10:95.
34. Ushijima, Y., C. Luo, F. Goshima, Y. Yamauchi, H. Kimura, and Y. Nishiyama. 2007. Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus. Microbes Infect. 9:142-149.
35. Whitley, R. J. 2001. Herpes simplex viruses, p. 2461-2509. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
36. Williams, D. A., and T. P. Cripe. 2006. Adventitious mutations in clinical grade vectors: an issue to consider? Mol. Ther. 13:831-832.
37. Worrad, D. M., and S. Caradonna. 1988. Identification of the coding sequence for herpes simplex virus uracil-DNA glycosylase. J. Virol. 62:4774-4777.
38. Worrad, D. M., and S. Caradonna. 1993. The herpes simplex virus type 2 UL3 open reading frame encodes a nuclear localizing phosphoprotein. Virology 195:364-376.
39. Yamada, H., Y. M. Jiang, H. Y. Zhu, K. Inagaki-Ohara, and Y. Nishiyama. 1999. Nucleolar localization of the UL3 protein of herpes simplex virus type 2. J. Gen. Virol. 80:2157-2164.